Li Naomi, Ngo Chau Tuan-Anh, Aleynikova Olga, Beauchemin Nicole, Richard Stéphane
Terry Fox Molecular Oncology Group and the Bloomfield Center for Research on Aging, Sir Mortimer B Davis Jewish General Hospital, Lady Davis Institute for Medical Research, Montréal, Québec H3T 1E2, Canada.
Department of Medicine and Oncology, McGill University, Montréal, Québec H3A 1A1, Canada.
Oncotarget. 2016 Nov 1;7(44):71651-71659. doi: 10.18632/oncotarget.12305.
The expression and activities of RNA binding proteins are frequently dysregulated in human cancer. Their roles, however, appears to be complex, with reports indicating both pro-tumorigenic and tumor suppressive functions. Here we show, using two classical mouse cancer models, that the role of KH-type RNA binding protein, Sam68, in tumor development can be influenced by the status of the p53 tumor suppressor. We demonstrate that in mice expressing wild type p53, Sam68-deficiency resulted in a higher incidence and malignancy of carcinogen-induced tumors, suggesting a tumor suppressive role for Sam68. In marked contrast, Sam68-haploinsufficiency significantly delayed the onset of tumors in mice lacking p53 and prolonged their survival, indicating that Sam68 accelerates the development of p53-deficient tumors. These findings provide considerable insight into a previously unknown relationship between Sam68 and the p53 tumor suppressor in tumorigenesis.
RNA结合蛋白的表达和活性在人类癌症中经常失调。然而,它们的作用似乎很复杂,有报道表明它们具有促肿瘤发生和肿瘤抑制功能。在这里,我们使用两种经典的小鼠癌症模型表明,KH型RNA结合蛋白Sam68在肿瘤发展中的作用可能受p53肿瘤抑制因子状态的影响。我们证明,在表达野生型p53的小鼠中,Sam68缺陷导致致癌物诱导肿瘤的发生率和恶性程度更高,这表明Sam68具有肿瘤抑制作用。与之形成鲜明对比的是,Sam68单倍体不足显著延迟了缺乏p53的小鼠肿瘤的发生并延长了它们的生存期,这表明Sam68加速了p53缺陷肿瘤的发展。这些发现为Sam68与p53肿瘤抑制因子在肿瘤发生过程中以前未知的关系提供了相当多的见解。